Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000
Reexamination Certificate
active
10472159
ABSTRACT:
The present invention relates to a compound represented by the formulawherein R1is an optionally substituted 5-membered heterocyclic group; X is a bond etc.; Q is a divalent hydrocarbon group having 1 to 20 carbon atoms; Y is a bond etc.; ring A is an aromatic ring optionally further having 1 to 3 substituents; Z is —(CH2)n—Z1— (n is an integer of 0 to 8 and Z1is a bond etc.) and the like; ring B is a 5-membered heterocycle optionally further having 1 to 3 substituents; W is a divalent saturated hydrocarbon group having 1 to 20 carbon atoms; R2is —OH etc., or a salt thereof. A pharmaceutical composition containing this compound is useful as a prophylactic or therapeutic agent of diseases such as diabetes mellitus and the like.
REFERENCES:
patent: 6967212 (2005-11-01), Cheng et al.
patent: 2031974 (1991-06-01), None
patent: 0612743 (1994-08-01), None
patent: 0629624 (1994-12-01), None
patent: 0710659 (1996-05-01), None
patent: 1067109 (2001-01-01), None
patent: 1 357 115 (2003-10-01), None
patent: WO 92/20350 (1992-11-01), None
patent: WO 96/13264 (1996-05-01), None
patent: WO 99/58510 (1999-11-01), None
patent: WO 00/01679 (2000-01-01), None
patent: WO 00/08002 (2000-02-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 01/17994 (2001-03-01), None
patent: WO 01/21602 (2001-03-01), None
patent: WO 01/38325 (2001-05-01), None
patent: WO 02/053547 (2002-07-01), None
Colagiuri et al., American Journal of Public Health, Sep. 2006, vol. 96, No. 9, pp. 1562-1569.
Bruno et al., Expert Opinion Emerging Drugs, (2005), 10(4), pp. 747-771.
Park, Diabetes Research and Clinical Practice 66S (2004), S33-S35.
Imoto Hiroshi
Kimura Hiroyuki
Maekawa Tsuyoshi
Momose Yu
Odaka Hiroyuki
Finnegan Henderson Farabow Garrett & Dunner LLP
Stockton Laura L.
Takeda Pharmaceutical Company Limited
LandOfFree
Five-membered heterocyclic alkanoic acid derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Five-membered heterocyclic alkanoic acid derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Five-membered heterocyclic alkanoic acid derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753043